Otsuka Group News

Keyword search

Search by company	Otsuka Holdings Otsuka Pharmaceutical Otsuka Pharmaceutical Factory Taiho Pharmaceutical Otsuka Warehouse Otsuka Chemical Otsuka Foods Otsuka Medical Devices Other
Search by category^*	Pharmaceuticals Business Nutraceuticals Business Consumer Products Business Others Products R&D Personnel Corporate * Business categories are based on the business segments described in the financial announcements.
Search by release date	-

July 12, 2017
Otsuka Pharmaceutical

Smart Medicine Container for Anti-stroke Medicine Approved for Sale in Japan
June 16, 2017
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory launches in Japan the anti-gastritis and anti-gastric ulcer agent “Rebamipide Tablets 100mg Otsuka”
June 8, 2017
Otsuka Pharmaceutical

Nalmefene, a Drug Candidate to Reduce Alcohol Consumption, Shows Positive Results from Phase III Trial in Japan
June 8, 2017
Otsuka Pharmaceutical

Quick NaviTM-Mycoplasma Diagnostic Kit to Launch in Japan
June 2, 2017
Taiho Pharmaceutical

Taiho Pharmaceutical to Construct Facility for Production of Highly Potent Pharmaceutical Ingredients
June 1, 2017
Otsuka Pharmaceutical

Otsuka to Continue Commitment to Support the Global Health Innovative Technology Fund (GHIT Fund)
May 30, 2017
Otsuka Pharmaceutical

Additional Formulation of Samsca® Granules 1% Available in Japan
May 29, 2017
Otsuka Pharmaceutical

Kenja-no-Kaimin Sleep Rhythm Support Asparagus-derived ingredient improves sleep-wake rhythms and enhances quality of sleep
May 23, 2017
Otsuka Pharmaceutical

Otsuka and Proteus Digital Heath Resubmit Application to US FDA for First Digital Medicine
May 22, 2017
Otsuka Pharmaceutical

Otsuka Announces Results of Phase 3 Data on Tolvaptan Under Development for ADPKD in U.S.
May 22, 2017
Otsuka Holdings Otsuka Pharmaceutical

Otsuka Announces Results of Phase 3 Data on Tolvaptan Under Development for ADPKD in U.S.
May 18, 2017
Taiho Pharmaceutical

Taiho Pharmaceutical Receives Approval for the Additional Indications of Complicated Skin and Soft Tissue Infections for ZOSYN®, an Injectable Antibiotic Combined with β-lactamase Inhibitor
May 15, 2017
Otsuka Pharmaceutical

Otsuka and Teva Sign Licensing Agreement for Japan on Prophylactic Migraine Drug Candidate Fremanezumab (TEV-48125)
May 15, 2017
Otsuka Pharmaceutical

Otsuka Agree to Purchase New Share Allocation of TWO CELLS
May 15, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Announces Construction of New Pharmaceutical Manufacturing Facility, Tokushima Mima Factory
May 11, 2017
Otsuka Pharmaceutical

Nutrition & Santé Inaugurates New Gluten-Free Manufacturing Facility
May 8, 2017
Otsuka Pharmaceutical Factory

Otsuka Pharmaceutical Factory enters into an agreement to acquire additional equity in its joint venture subsidiary, Otsuka Pharmaceutical India Private Limited (OPI)
May 8, 2017
Otsuka Holdings

Otsuka Pharmaceutical Factory, enters into an agreement to acquire additional equity in its joint venture subsidiary, Otsuka Pharmaceutical India Private Limited (OPI)
May 2, 2017
Otsuka Pharmaceutical

Otsuka and Lundbeck Announce Results of Brexpiprazole on Symptoms of Agitation Related to Alzheimer's-type Dementia
May 2, 2017
Otsuka Holdings Otsuka Pharmaceutical

Otsuka and Lundbeck Announce Results of Brexpiprazole on Symptoms of Agitation Related to Alzheimer’s-type Dementia
April 26, 2017
Otsuka Pharmaceutical

Otsuka and Akebia Concludes Licensing Agreement for Akebia's Renal Anemia Drug Vadadustat - Development and marketing territories include Europe, China, etc. -
April 14, 2017
Otsuka Pharmaceutical

Renewal of Fibe-Mini Dietary Fiber Beverage Food for Specified Health Uses Now Contains Lycopene - Renewal Launch with New Package and Logo Design -
April 4, 2017
Otsuka Pharmaceutical

Amino-Value 4000 and Amino-Value Powder 8000 Renewed as Foods with Function Claim "Alleviates Fatigue Caused by Physical Activity"
April 3, 2017
Taiho Pharmaceutical

Taiho Pharmaceutical Completely Redesigns Official Website
April 3, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Introduces New BODYMAINTÉ Brand BODYMAINTÉ Jelly, a conditioning food to be launched in April 2017
March 30, 2017
Otsuka Holdings

Otsuka Holdings appoints Board Members and Audit & Supervisory Board Members
March 27, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Health-related Partnership with Fukui Prefecture
March 24, 2017
Otsuka Pharmaceutical

Otsuka Pharmaceutical Enters into Comprehensive Partnership Agreement with Ibaraki Prefecture
March 24, 2017
Otsuka Holdings Otsuka Pharmaceutical

Lundbeck and Otsuka’s brexpiprazole for adult patients with schizophrenia accepted for review by EMA
March 23, 2017
Otsuka Pharmaceutical

Ribociclib (LEE011) Receives Regulatory Approval in U.S. as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer with an aromatase inhibitor